secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2023-07-20T23:59:59+00:00
Accession:  0001372514-23-000107
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora receives Nasdaq deficiency notice for stock below $1.00
-------------------------------------------------------------

- Bid price closed below $1.00 for 30 consecutive business days as of July 18, 2023.
- Company has 180 calendar days, until January 15, 2024, to regain compliance.
- To cure, closing bid price must be at least $1.00 for 10 consecutive trading days.
- If not cured, Kiora may be eligible for a second 180-day period if other listing standards are met.
- Company is evaluating options but cannot assure compliance or continued listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251423000107/0001372514-23-000107-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251423000107/kprx-20230718.htm
  HTML page:      https://secwatch.observer/filing/0001372514-23-000107

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer